Bicalutamide (Casodex®) in the treatment of prostate cancer
- 1 February 2004
- journal article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 4 (1) , 37-48
- https://doi.org/10.1586/14737140.4.1.37
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2002
- Clinical staging of prostate cancer: Reproducibility and clarification of issuesInternational Journal of Cancer, 2001
- LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARSJournal of Urology, 2000
- Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trialsThe Lancet, 2000
- Anemia After OrchiectomyAmerican Journal of Hematology, 1998
- Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerNew England Journal of Medicine, 1998
- Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogensUrology, 1997
- Role of maximal androgen blockade in advanced prostate cancerThe Prostate, 1994
- Quality of life and psychosocial status in stage D prostate cancerQuality of Life Research, 1992